Twist Bioscience

Yahoo Finance • 11 days ago

Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT

Twist Bioscience Corporation (NASDAQ:TWST) is one of the best gene-editing stocks to buy according to hedge funds. On November 4, Steven Etoch, an analyst at Stephens, began coverage of Twist Bioscience Corporation (NASDAQ:TWST). Etoch ass... Full story

Yahoo Finance • 12 days ago

Is Twist Bioscience Corporation (TWST) a Compelling Risk-Regarded Opportunity?

Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Global equities continue to rally in the third quarter, the period w... Full story

Yahoo Finance • 15 days ago

Twist Bioscience outlines 13–15.5% revenue growth target for 2026 as AI-driven orders accelerate

Earnings Call Insights: Twist Bioscience Corporation (TWST) Q4 2025 MANAGEMENT VIEW * CEO Emily Leproust highlighted a record quarter with $99 million in revenue and 17% year-over-year growth, noting "our 11th quarter of consecutive gr... Full story

Yahoo Finance • 15 days ago

Twist Bioscience GAAP EPS of -$0.45 misses by $0.03, revenue of $99M beats by $1.64M

* Twist Bioscience press release [https://seekingalpha.com/pr/20307952-twist-bioscience-announces-fiscal-2025-fourth-quarter-and-full-year-financial-results] (TWST [https://seekingalpha.com/symbol/TWST]): Q4 GAAP EPS of -$0.45 misses by... Full story

Yahoo Finance • 17 days ago

Cathie Wood doubles down on Alibaba: ARK Invest snaps up $25M in Chinese tech stocks

This article first appeared on GuruFocus. ARK Invest funds boosted holdings in Alibaba (NYSE:BABA) and Baidu (NASDAQ:BIDU) while trimming stakes in Reddit (RDDT), Exact Sciences (EXAS) and Iridium Communications (IRDM), according to Wedne... Full story

Yahoo Finance • 19 days ago

Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law Firm

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Twist Bioscience Corporation (NASDAQ: TWST) breached their fiduciary duties to sha... Full story

Yahoo Finance • 24 days ago

Twist Bioscience (TWST): Exploring Valuation Following Fresh Analyst Coverage and Product Launch Collaboration

Twist Bioscience (TWST) saw fresh attention after Stephens launched analyst coverage, highlighting the company’s innovative DNA synthesis technology and recent moves. These moves include a new sequencing workflow with Element Biosciences a... Full story

Yahoo Finance • last month

Multiple Headwinds Hit Twist BioScience Corp. (TWST) in Q3

Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets continued their momentum that began in early April, reaching new all-time... Full story

Yahoo Finance • 2 months ago

A Fresh Look at Twist Bioscience’s (TWST) Valuation After Its Recent 27% Share Price Surge

Twist Bioscience (TWST) has seen its share price climb nearly 27% over the past month, sparking some renewed interest among biotech investors. The stock’s movement stands out in a sector that has been anything but predictable recently. Se... Full story

Yahoo Finance • 2 months ago

Truist Finl Reports Before the Open on 10/17 -- Options Contracts Expire the Same Day

According to NextEarningsDate.com, the Truist Finl (NYSE: TFC) TFC next earnings date is projected to be 10/17 before market open, with earnings estimates of $0.99/share on $5.18 Billion of revenue. Looking back, the recent Truist Finl ea... Full story

Yahoo Finance • 2 months ago

Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design

Study and red-teaming exercise led by Microsoft brought together consortium of scientific and industry experts Twist remains at the forefront of biosecurity innovation, demonstrating leadership in both policy engagement and technical solu... Full story

Yahoo Finance • 2 months ago

Interesting TWST Put And Call Options For November 21st

Investors in Twist Bioscience Corp (Symbol: TWST) saw new options become available this week, for the November 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TWST options chain for the new No... Full story

Yahoo Finance • 3 months ago

Oversold Conditions For Twist Bioscience (TWST)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the R... Full story

Yahoo Finance • 3 months ago

Cathie Wood's ARK ETF bolsters biotech, trims defense stock

Cathie Wood’s ARK ETF published their daily trades for Monday, August 18th, 2025, showcasing a continued focus on the biotech sector while reducing exposure in defense. The largest trade of the day was the purchase of 170,471 shares of Gen... Full story

Yahoo Finance • 3 months ago

Cathie Wood's ARK ETF focuses on Roblox and CoreWeave stock buys

Cathie Wood’s ARK ETF released its daily trades for Friday, August 15th, 2025, revealing a series of strategic investments and divestments across various sectors. The largest transaction of the day was the purchase of 125,799 shares of Rob... Full story

Yahoo Finance • 4 months ago

[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global AI in Synthetic Biology Market size & share revenue was valued at approximately USD... Full story

Yahoo Finance • 4 months ago

Twist Bioscience earnings beat by $0.86, revenue topped estimates

Investing.com - Twist Bioscience (NASDAQ: TWST) reported third quarter EPS of $0.33, $0.86 better than the analyst estimate of $-0.53. Revenue for the quarter came in at $96.06M versus the consensus estimate of $95.61M. Twist Bioscience’s... Full story

Yahoo Finance • 4 months ago

Twist Bioscience outlines $374M-$376M 2025 revenue target while expanding NGS and SynBio portfolio

Earnings Call Insights: Twist Bioscience (TWST) Q3 2025 MANAGEMENT VIEW * CEO Emily Marine Leproust stated the company added hundreds of new customers and introduced the first in a series of planned SynBio product line expansions, emph... Full story

Yahoo Finance • 4 months ago

Earnings call transcript: Twist Bioscience Q3 2025 sees revenue rise 18%

Twist Bioscience Corp (TWST) reported its Q3 2025 earnings, showing a significant 18% year-over-year increase in revenue, reaching $96.1 million. Despite this growth, the company’s stock saw a decline of 5.58% in premarket trading, with sh... Full story

Yahoo Finance • 4 months ago

Twist Bioscience Corp (NASDAQ:TWST) Reports Mixed Q3 2025 Results with Revenue Miss and EPS Beat

Twist Bioscience Corp. (NASDAQ:TWST [https://www.chartmill.com/stock/quote/TWST/profile]) reported its fiscal third-quarter 2025 financial results, delivering mixed performance relative to analyst expectations. The synthetic DNA manufactur... Full story